Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)

    November 2025 in “ SKIN The Journal of Cutaneous Medicine ”
    Arash Mostaghimi, Melinda Gooderham, Charles Lynde, Rodney Sinclair, Brett King, Maria Hordinsky, Lidia Rudnicka, Emma Guttman‐Yassky, Sebastian Meerwein, Ahmed M. Soliman, Xianwei Bu, Chenyang Duan, Tianshuang Wu, Henrique Teixeira, Andreas Lazar, Thierry Passeron

    We don't know much about this study yet.

    We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    Discuss this study in the Community →